Neurocrine Biosciences (NBIX) Reports Q3 Loss of $0.13
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $149.50 --0%
Revenue Growth %: +30.8%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +30.8%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.13), versus ($0.43) reported last year.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- CIENA (CIEN) PT Raised to $450 at Morgan Stanley
- Oscar Health Inc (OSCR) PT Raised to $48 at Piper Sandler
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
